Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer—A New Diagnostic and Therapeutic Target?

SIMPLE SUMMARY: Prostate-specific membrane antigen (PSMA)-targeted therapy represents a promising therapeutic option for the treatment of advanced carcinoma, but data on the relevance of PSMA-targeted diagnostics and therapy for anaplastic (ATC) and poorly differentiated (PDTC) thyroid carcinoma are...

Descripción completa

Detalles Bibliográficos
Autores principales: Wächter, Sabine, Di Fazio, Pietro, Maurer, Elisabeth, Manoharan, Jerena, Keber, Corinna, Pfestroff, Andreas, Librizzi, Damiano, Bartsch, Detlef K., Luster, Markus, Eilsberger, Friederike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616254/
https://www.ncbi.nlm.nih.gov/pubmed/34830843
http://dx.doi.org/10.3390/cancers13225688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616254/
https://www.ncbi.nlm.nih.gov/pubmed/34830843
http://dx.doi.org/10.3390/cancers13225688

Ejemplares similares